Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

• Status: Completed
• Trial end date: 2007-09-01

Summary

Antidepressant medicines sometimes cause sexual side effects. The purpose of this study is to determine whether the sexual dysfunction sometimes caused by selective serotonin reuptake inhibitor (SSRI) antidepressant medications can be reversed by treatment with Requip (ropinirole), a medicine which is used to treat Parkinson's Disease and restless leg syndrome.

• Phase: Phase 4

Details

• Lead Sponsor: St. Luke's-Roosevelt Hospital Center
• Collaborator: GlaxoSmithKline
• Treatments: Antidepressive Agents; Ropinirole; Serotonin; Serotonin Uptake Inhibitors